| Methods |
Randomized trial
Study period: January through December 1987 |
| Participants |
Inclusion criteria: women with infections or febrile morbidity defined as temperature of at least 38 °C on 2 successive measurements 24 hours apart after abortion or delivery for postpartum endometritis participants
Setting: Italy (at least 2 sites)
Number of participants: n = 95, of which 25 were cases of postpartum endometritis |
| Interventions |
Sulbactam/ampicillin 1 g/2 g iv every 8 hours (n = 12) vs cefotetan 2 g iv every 12 hours (n = 13) |
| Outcomes |
Therapeutic failure |
| Notes |
Outcomes for postpartum women were identified. There were 19 vaginal births and 6 cesarean births
Pharmaceutical sponsorship ‐ explicit |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Random sequence generation (selection bias) |
Unclear risk |
States “according to a random schedule” without further description |
| Allocation concealment (selection bias) |
Unclear risk |
Not stated |
| Blinding of participants and personnel (performance bias)
All outcomes |
Unclear risk |
Not stated |
| Blinding of outcome assessment (detection bias)
All outcomes |
Unclear risk |
Not stated |
| Incomplete outcome data (attrition bias)
All outcomes |
Low risk |
No drop‐outs |
| Selective reporting (reporting bias) |
Unclear risk |
The protocol is not available, insufficient information to permit judgment |
| Other bias |
High risk |
Pharmaceutical sponsorship ‐ evident |
